Fundraising FoxAisling Capital — 2020 Investments
5 investments dated 2020 · listed companies and verified rows first · show all
Monte Rosa develops molecular glue degrader (MGD) therapeutics using MGD chemistry, artificial intelligence, structural biology, and proteomics to target previously undruggable or inadequately drugged disease targets.
AI & Machine LearningBiotechDeep TechHealthtechBoston, US
Markus Warmuth(Chief Executive Officer)inSharon Townson(Ph.D., Chief Scientific Officer)inJohn Castle(Ph.D., Chief Data and Information Officer)inFilip Janku(M.D., Ph.D., Chief Medical Officer)inPhil Nickson(Ph.D., J.D., Chief Business and Legal Officer)inMagnus Walter(DPhil, Chief Technology Officer)in
Co-investorsHBM PartnersNew Enterprise Associates (NEA)Versant VenturesAmzak HealthAvoro Capital AdvisorsGV (Google Ventures)+4 more
Biomea Fusion is a clinical-stage company developing oral small-molecule drugs for diabetes, obesity, and metabolic diseases, with lead programs including icovamenib, a menin inhibitor, and BMF-650, a GLP-1 receptor agonist.
BiotechRedwood City, US
Thomas Butler(Executive Officer, Director)inRamses Erdtmann(Director, Executive Officer)inMichael J.M. Hitchcock(Interim Chief Executive Officer and Director)Rainer (Ramses) Erdtmann(Chief Operating Officer, President and Director)in
Reneo is an asset and investment management platform for decarbonizing residential real estate portfolios in Germany.
Climate TechEnterprise SoftwarePropTechGermany, DE
Lennart Börner(Founder & Co-CEO)inAlexander Graubner-Müller(Founder & Co-CEO)in
Co-investorsFoundamentalAbingworthAmzak HealthEurazeoLakestarLundbeckfonden Ventures+4 more
Xoilac TV is a free online football (soccer) live-streaming platform serving fans in Vietnam, offering Full HD match broadcasts of European, Asian, Vietnamese, and international competitions.
ConsumerMedia & EntertainmentSports Tech
Co-investorsChiesi VenturesNew Enterprise Associates (NEA)Pappas CapitalRiverVest Venture PartnersAbingworthAmzak Health+3 more
Clinical-stage biotech developing cell therapy products for transplant and autoimmune conditions
BiotechLouisville, US
Suzanne Ildstad(Executive Officer, Director)Scott Requadt(Executive Officer, Director)Geoff Mackay(Director)Francois Nader(Director)
BoardSandip Agarwala(Director)inMark McDade(Director)in
Co-investorsKeyhorse CapitalLongitude CapitalQiming Venture Partners USAViking GlobalBlackstone Life SciencesCitadel+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.